MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

oligodendroglioma

(UMLS:C0028945)

Definition:: A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655)
UMLS ID:: C0028945
MeSH ID:: D009837

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.600.380.590|C04.557.470.670.380.590|C04.557.580.625.600.380.590

Synonym(s)

oligodendroglioma

Oligodendroglioma

Oligodendroglioma NOS

Oligodendroglioma, NOS

Oligodendroglioma, Not Otherwise Specified

Oligodendroglioma, no ICD-O subtype

Oligodendroglioma, no International Classification of Diseases for Oncology subtype

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Carbamazepine	FAERS: 3		US FAERS
2	Glatiramer Acetate	FAERS: 2		US FAERS
3	Insulin Detemir	FAERS: 2		US FAERS
4	Phenytoin	FAERS: 2		US FAERS
5	Bortezomib	FAERS: 1		US FAERS
6	Clozapine	FAERS: 1		US FAERS
7	Everolimus	FAERS: 1		US FAERS
8	Ondansetron	FAERS: 1		US FAERS
9	Oxcarbazepine	FAERS: 1		US FAERS
10	Temozolomide	FAERS: 1 Canada Vigilance: 3	20842591	CTD OFFSIDES Canada Vigilance US FAERS
11	Tenofovir	FAERS: 1		US FAERS
12	carbidopa, levodopa drug combination	FAERS: 1		US FAERS
13	tofacitinib	FAERS: 1		US FAERS
14	Carmustine		15332326	CTD
15	Ethylnitrosourea		7231638 17160924	CTD
16	Irinotecan		18480965	CTD
17	Lomustine		View details 7931469 15015656 19901104 20842591 21246521	CTD
18	Procarbazine		View details 7931469 15015656 19901104 20842591 21246521	CTD
19	Solifenacin Succinate			OFFSIDES
20	Terbutaline			OFFSIDES
21	Thiotepa		11303620	CTD
22	Valproic Acid			OFFSIDES
23	Vincristine		View details 7931469 15015656 19901104 20842591 21246521	CTD
24	Vitamin D			OFFSIDES
25	Zidovudine			OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Medulloblastoma	57.5%
2	Astrocytoma	55.8%
3	Ependymoma	55.8%
4	Ganglioglioma	55.8%
5	gliosarcoma	55.8%
6	Anaplastic astrocytoma	55.8%
7	Ganglioneuroma	46%
8	Glioblastoma	41.7%
9	Glioblastoma Multiforme	41.7%
10	Craniopharyngioma	34.4%
11	Neuroectodermal Tumor, Melanotic	34.4%
12	Neuroendocrine Tumors	34.4%
13	leukemia	31.7%
14	Retinoblastoma	29.5%
15	melanoma	28.7%
16	Optic Nerve Glioma	27%
17	Adenoma, Acidophil	27%
18	Histiocytic Disorders, Malignant	25.5%
19	Adenoma	24.8%
20	Carcinoma	24.8%
21	Epithelioma	24.8%
22	Meningioma	24.6%
23	Chordoma	24%
24	Teratoma	24%
25	Germinoma	24%
26	Teratocarcinoma	24%
27	Trophoblastic Neoplasms	23.5%
28	Carcinoid Tumor	23.5%
29	Neurilemmoma	23%
30	Basal cell carcinoma	22.9%
31	Carcinoma, Papillary	22.9%
32	Squamous cell carcinoma	22.9%
33	Cystadenoma	22.9%
34	Mesothelioma	22.9%
35	Carcinoma, Basal Cell	22.9%
36	Neuroblastoma	22.8%
37	Neoplasms, Germ Cell and Embryonal	21.3%
38	Germ Cell Cancer	21.3%
39	Lymphoma	21.3%
40	Carcinosarcoma	21.2%
41	Hemangiosarcoma	21.2%
42	lymphangiosarcoma	21.2%
43	Hamartoma	21%
44	Neoplasms, Hormone-Dependent	21%
45	Neoplasms, Multiple Primary	21%
46	Paraneoplastic Syndromes	21%
47	Precancerous Conditions	21%
48	Neoplasms, Second Primary	21%
49	Paraganglioma	20.9%
50	Neoplasms, Glandular and Epithelial	20.7%
51	Carcinoma, Ehrlich Tumor	20.1%
52	Carcinoma, Lewis Lung	20.1%
53	Dermoid Cyst	19.5%
54	Composite Lymphoma	19.4%
55	Melanoma, Experimental	19.1%
56	Ganglioneuroblastoma	19%
57	Cystadenocarcinoma	18.7%
58	Mucoepidermoid Carcinoma	18.7%
59	Leukemia, Experimental	18.5%
60	Neuroectodermal Tumors	18.4%
61	Hutchinson's Melanotic Freckle	18.2%
62	Melanoma, Amelanotic	18.2%
63	Leukemia, Plasma Cell	17.6%
64	Carcinoma 256, Walker	17.5%
65	Cyst	17%
66	Neoplastic Processes	17%
67	Neoplastic Syndromes, Hereditary	17%
68	Pregnancy Complications, Neoplastic	17%
69	Ameloblastoma	16.8%
70	Angiokeratoma	16.8%
71	Hemangioma	16.8%
72	hemangiopericytoma	16.8%
73	Lymphangioma	16.8%
74	Mesenchymoma	16.8%
75	Nevus	16.8%
76	Hepatoblastoma	16.8%
77	Mixed Tumor, Mullerian	16.8%
78	Angiofibroma	16.8%
79	Sarcoma	16.8%
80	Neoplasms, Experimental	16.8%
81	Carcinoma, Lobular	16.7%
82	Choriocarcinoma	16.2%
83	Malignant Carcinoid Syndrome	16.2%
84	Neoplasms, Neuroepithelial	16%
85	Gliomatosis cerebri	16%
86	Leukemia, Radiation-Induced	16%
87	Acanthoma	16%
88	Chondrosarcoma	15.3%
89	leiomyosarcoma	15.3%
90	liposarcoma	15.3%
91	synovial sarcoma	15.3%
92	Angiomyolipoma	15.3%
93	Clear Cell Sarcoma of Soft Tissue	15.3%
94	Alveolar Soft Part Sarcoma	15.3%
95	Sarcoma, Myeloid	15.3%
96	Adenofibroma	14.7%
97	Fibroadenoma	14.7%
98	Bowen's Disease	14.6%
99	Adenocarcinoma	14.3%
100	Carcinoma in Situ	14.3%
101	Carcinoma, Transitional Cell	14.3%
102	Papilloma	14.3%
103	Pseudomyxoma Peritonei	14.3%
104	Papillomatosis	14.3%
105	Adenomatosis, Pulmonary	14.3%
106	Adenomatous Polyps	14.3%
107	Carcinoma, Large Cell	14.3%
108	Carcinoma, Small Cell	14.3%
109	Pheochromocytoma	14.2%
110	Neoplasms, Radiation-Induced	14%
111	Multiple Endocrine Neoplasia	13.8%
112	Plasmacytoma	13.5%
113	Sarcoma, Experimental	13.5%
114	Dysgerminoma	13.5%
115	Neuroma	13.5%
116	Seminoma	13.5%
117	Malignant histiocytosis	13.5%
118	Histiocytic sarcoma	13.5%
119	Thymoma	13.4%
120	Endometrial Stromal Sarcoma	12.9%
121	Fibrosarcoma	12.4%
122	Osteosarcoma	12.4%
123	Leukemia L1210	12.2%
124	Leukemia P388	12.2%
125	Hodgkin Disease	11.2%
126	Lymphoma, Non-Hodgkin	11.2%
127	Paraneoplastic Encephalomyelitis	11%
128	Lymphangioleiomyomatosis	11%
129	Malignant Fibrous Histiocytoma	10.9%
130	Carcinoid Heart Disease	10.9%
131	Mammary Neoplasms, Experimental	10.9%
132	Tuberous Sclerosis	10.8%
133	Nephroblastoma	10.8%
134	Abdominal Neoplasms	10.6%
135	Erythroplasia	10.6%
136	Follicular cyst	10.6%
137	Head and Neck Neoplasms	10.6%
138	Mucocele	10.6%
139	Pilonidal Cyst	10.6%
140	Soft Tissue Neoplasms	10.6%
141	Thoracic Neoplasms	10.6%
142	Thyroglossal Cyst	10.6%
143	Synovial Cyst	10.6%
144	Aberrant Crypt Foci	10.6%
145	Basal Cell Nevus Syndrome	10.4%
146	Hepatocellular Adenoma	10.1%
147	Acoustic Neuroma	9.8%
148	Primary amyloidosis	9.7%
149	Phyllodes Tumor	9.5%
150	Glioma	9.5%
151	Hemangioendothelioma	9.5%
152	Lipoma	9.5%
153	Myoma	9.5%
154	Myxoma	9.5%
155	Angiolipoma	9.5%
156	Myelolipoma	9.5%
157	Neoplasms, Bone Tissue	9.5%
158	Neoplasms, Fibrous Tissue	9.5%
159	Smooth Muscle Tumor	9.5%
160	Desmoplastic Small Round Cell Tumor	9.5%
161	Malignant Glioma	9.5%
162	Chondroma	9.5%
163	Enchondroma	9.5%
164	Rhabdomyosarcoma	9.5%
165	Giant Cell Tumor of Bone	9.5%
166	Lymphomatoid Granulomatosis	9.4%
167	Sarcoma 180	9.3%
168	Neurofibrosarcoma	9.2%
169	Adenoid Cystic Carcinoma	9.1%
170	Adenocarcinoma, Clear Cell	9.1%
171	Cholangiocarcinoma	9.1%
172	Cervical Intraepithelial Neoplasia	9.1%
173	neurofibroma	9%
174	Carcinoma, Pancreatic Ductal	8.9%
175	Prolactinoma	8.8%
176	Growth Hormone-Secreting Pituitary Adenoma	8.8%
177	Digestive System Neoplasms	8.8%
178	Endocrine Gland Neoplasms	8.8%
179	Eye Neoplasms	8.8%
180	Nervous System Neoplasms	8.8%
181	Bone neoplasms	8.6%
182	Leukoplakia	8.6%
183	Lymphocele	8.6%
184	Pancreatic Cyst	8.6%
185	Skin Neoplasms	8.6%
186	Hematologic Neoplasms	8.6%
187	Barrett Esophagus	8.5%
188	Breast Cyst	8.5%
189	Actinic keratosis	8.5%
190	Mediastinal Cyst	8.5%
191	Neoplasm Invasiveness	8.5%
192	Neoplasm Metastasis	8.5%
193	Neoplasm Recurrence, Local	8.5%
194	Parovarian Cyst	8.5%
195	Pericardial Cyst	8.5%
196	Splenic Neoplasms	8.5%
197	Thymic Cyst	8.5%
198	Carcinogenesis	8.5%
199	Myxoid cyst	8.5%
200	Metastasis	8.5%
201	Mesoblastic Nephroma	8.3%
202	Dermatofibrosarcoma	8.1%
203	Dermatofibrosarcoma Protuberans	8.1%
204	Carcinoma, Ovarian Epithelial	7.8%
205	Vipoma	7.8%
206	Hydatidiform Mole	7.7%
207	Leukemia, Myelomonocytic, Chronic	7.6%
208	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	7.6%
209	Waldenstrom Macroglobulinemia	7.6%
210	Multiple Myeloma	7.6%
211	Multiple Endocrine Neoplasia Type 1	7.3%
212	Corpus Luteum Cyst	7%
213	Ovarian Cysts	7%
214	Adenomatous Polyposis Coli	7%
215	Liver Neoplasms, Experimental	6.9%
216	Parathyroid Neoplasms	6.6%
217	Peritoneal Neoplasms	6.6%
218	Thyroid Neoplasm	6.6%
219	Thyroid carcinoma	6.6%
220	Alveolar rhabdomyosarcoma	6.6%
221	Mastocytosis	6.5%
222	Sturge-Weber Syndrome	6.5%
223	Klatskin Tumor	6.5%
224	Gastrointestinal Stromal Tumors	6.5%
225	Hemangioma, Cavernous	6.4%
226	Leukemia, T-Cell	6.4%
227	Leukemia, B-Cell	6.4%
228	Lymphoma, Follicular	6.3%
229	T-Cell Lymphoma	6.3%
230	Mantle cell lymphoma	6.3%
231	oligodendroglioma	6.3%
232	Anaplastic Oligodendroglioma	6.3%
233	Nasopharyngeal carcinoma	6.3%
234	Choledochal Cyst	6.2%
235	Peutz-Jeghers Syndrome	6%
236	fibroma	5.9%
237	Fibromatosis	5.9%
238	Osteoblastoma	5.9%
239	Osteoma	5.9%
240	Rhabdomyoma	5.9%
241	Chondromatosis	5.9%
242	Hemangioblastoma	5.9%
243	Lymphoma, Extranodal NK-T-Cell	5.9%
244	Pancreatic Neoplasm	5.9%
245	insulinoma	5.8%
246	granulosa cell tumor	5.7%
247	Retroperitoneal Neoplasms	5.6%
248	Adrenocortical carcinoma	5.6%
249	Tracheal Neoplasms	5.2%
250	Leukoplakia, Oral	5.1%
251	Paraneoplastic Cerebellar Degeneration	5.1%
252	Renal Cell Carcinoma	4.9%
253	Papillary Renal Cell Carcinoma	4.9%
254	Mastocytoma	4.8%
255	Mastocytosis, Systemic	4.8%
256	Leukemia, Myeloid, Chronic-Phase	4.7%
257	Gastrinoma	4.7%
258	Glucagonoma	4.7%
259	Carcinoma, Endometrioid	4.7%
260	Mouth Neoplasms	4.6%
261	Central Nervous System Neoplasms	4.6%
262	Vascular Neoplasms	4.6%
263	Thymus Neoplasms	4.6%
264	Genital Neoplasms, Female	4.5%
265	Pancreatic Pseudocyst	4.5%
266	Lymphatic Metastasis	4.5%
267	Neoplasms, Unknown Primary	4.5%
268	Leukemic Infiltration	4.5%
269	Breast Neoplasms, Male	4.5%
270	Neoplasm Micrometastasis	4.5%
271	Triple Negative Breast Neoplasms	4.5%
272	Esophageal Neoplasms	4.5%
273	Limbic Encephalitis	4.4%
274	Denys-Drash Syndrome	4.4%
275	Fibromatosis, Aggressive	4.1%
276	Fibromatosis, Abdominal	4.1%
277	Lambert-Eaton Myasthenic Syndrome	4%
278	Testicular Neoplasms	4%
279	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4%
280	Leukemia, Large Granular Lymphocytic	4%
281	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4%
282	Lymphoma, T-Cell, Cutaneous	3.9%
283	Lymphoma, AIDS-Related	3.9%
284	Enteropathy-Associated T-Cell Lymphoma	3.9%
285	Primary Effusion Lymphoma	3.9%
286	Xeroderma Pigmentosum	3.9%
287	Adrenal Gland Neoplasms	3.9%
288	Gastrointestinal Neoplasms	3.9%
289	Genital Neoplasms, Male	3.9%
290	Liver neoplasms	3.9%
291	Uveal Neoplasms	3.9%
292	Urologic Neoplasms	3.8%
293	Sebaceous Gland Neoplasms	3.8%
294	Spinal Neoplasms	3.8%
295	Bone Marrow Neoplasms	3.8%
296	Polycystic Ovary Syndrome	3.7%
297	Leydig Cell Tumor	3.7%
298	Thyroid Nodule	3.7%
299	Opsoclonus-Myoclonus Syndrome	3.6%
300	Myelitis, Transverse	3.2%
301	Burkitt Lymphoma	3%
302	ovarian neoplasm	2.9%
303	Dupuytren Contracture	2.8%
304	Urticaria Pigmentosa	2.8%
305	Mycosis Fungoides	2.8%
306	Lymphomatoid Papulosis	2.8%
307	Plasmablastic lymphoma	2.8%
308	Nose Neoplasms	2.7%
309	Meningeal Neoplasms	2.6%
310	Pituitary Adenoma	2.5%
311	Pituitary Neoplasms	2.5%
312	Palatal Neoplasms	2.3%
313	Zollinger-Ellison syndrome	2.3%
314	Ear Neoplasms	2.2%
315	Eyelid Neoplasms	2.2%
316	Lung Neoplasms	2.2%
317	Pleural Neoplasms	2.2%
318	Cell Transformation, Viral	2.2%
319	Brain Neoplasms	2.2%
320	Salivary Gland Neoplasms	2.2%
321	Spinal Cord Neoplasms	2.2%
322	Tongue Neoplasms	2.2%
323	Uterine Neoplasms	2.1%
324	Vaginal Neoplasms	2.1%
325	Vulvar Neoplasms	2.1%
326	Uterine Cancer	2.1%
327	Fallopian Tube Neoplasms	2.1%
328	Sezary Syndrome	2.1%
329	Pharyngeal Neoplasms	1.9%
330	Central Nervous System Cysts	1.9%
331	Bile Duct Neoplasms	1.9%
332	gallbladder neoplasm	1.9%
333	Intestinal Neoplasms	1.9%
334	Penile Neoplasms	1.9%
335	Prostatic Neoplasms	1.9%
336	Stomach Neoplasms	1.9%
337	Polycythemia Vera	1.8%
338	Laryngeal neoplasm	1.7%
339	Bladder Neoplasm	1.6%
340	Kidney Neoplasm	1.6%
341	Ureteral Neoplasms	1.6%
342	Urethral Neoplasms	1.6%
343	Meningeal Carcinomatosis	1.6%
344	Bronchial Neoplasms	1.4%
345	Multiple Pulmonary Nodules	1.3%
346	Supratentorial Neoplasms	1.3%
347	Endometrial Neoplasms	1.3%
348	Hypopharyngeal Neoplasms	1.2%
349	Pleural Effusion, Malignant	1.2%
350	Hypopharyngeal Cancer	1.2%
351	Parotid Neoplasms	1.1%
352	Prostatic Neoplasms, Castration-Resistant	1.1%
353	Nelson Syndrome	1.1%
354	Cecal Neoplasms	1%
355	Duodenal Neoplasms	1%
356	Brain Stem Neoplasms	0.9%
357	Nasopharyngeal Neoplasms	0.9%
358	Colorectal Neoplasms	0.9%
359	Paranasal Sinus Neoplasms	0.8%
360	Tonsillar Neoplasms	0.8%
361	Cerebellar Neoplasms	0.8%
362	Choroid Plexus Papilloma	0.7%
363	Radicular Cyst	0.7%
364	Appendiceal Neoplasms	0.7%
365	Colonic Neoplasms	0.7%
366	Rectal Neoplasms	0.7%
367	Maxillary Sinus Neoplasms	0.6%
368	Anus Neoplasms	0.5%
369	Sigmoid Neoplasms	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262